Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06569537 · ClinicalTrials.gov registry record · Phase 4

Comparison of Compounded Topical Anesthetics

A Phase 4 study of Procedural Pain, sponsored by Dartmouth-Hitchcock Medical Center.

Recruiting
Registry status
Phase 4
Development phase
64
Enrollment target
1
Study location

NCT06569537 is a Phase 4 study of Procedural Pain that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 64 participants, above the 54-participant average among 9 other Procedural Pain trials with a reported enrollment target (19% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06569537, a Phase 4 study of Procedural Pain, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.

RECRUITING
Registry status
Phase 4
Development phase
64 participants
Enrollment target
1
Study location

Study Summary

The primary objective for this pilot study is to evaluate the efficacy of the compounded topical anesthetic Benzocaine 20%/ Lidocaine 8%/Tetracaine 4% (BLT) compared to 4% Lidocaine topical in providing relief of pain during IPL, PDL, and microneedling procedures.

Conditions Studied

Interventions

  • DRUG Lidocaine topical
  • DRUG BLT

Study Locations (1)

New Hampshire

  • Dartmouth Hitchcock Dermatology Clinic - Lebanon

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2024-10-22
Est. Completion 2026-01
Phase Phase 4

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT06569537

The ClinicalTrials.gov registry entry for NCT06569537 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 54-participant average among 9 other Procedural Pain trials with a reported enrollment target (19% higher). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Procedural Pain appearing as the primary indexed condition, and to 2 interventions - of which Lidocaine topical is the first listed.

NCT06569537 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.

Frequently Asked Questions

What is clinical trial NCT06569537 about?

NCT06569537 is a clinical study titled "Comparison of Compounded Topical Anesthetics". The primary objective for this pilot study is to evaluate the efficacy of the compounded topical anesthetic Benzocaine 20%/ Lidocaine 8%/Tetracaine 4% (BLT) compared to 4% Lidocaine topical in providing relief of pain during IPL, PDL, and microneedling procedures.

What is the current status of trial NCT06569537?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2024-10-22. Estimated completion is 2026-01.

What conditions does trial NCT06569537 study?

This clinical trial studies the following conditions: Procedural Pain.

What interventions are being tested in trial NCT06569537?

The interventions under investigation include: Lidocaine topical (DRUG), BLT (DRUG).

Who is sponsoring clinical trial NCT06569537?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06569537 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Procedural Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.